Hiroshi Sato

15.6k total citations · 3 hit papers
319 papers, 10.9k citations indexed

About

Hiroshi Sato is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Nephrology. According to data from OpenAlex, Hiroshi Sato has authored 319 papers receiving a total of 10.9k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Cardiology and Cardiovascular Medicine, 65 papers in Molecular Biology and 57 papers in Nephrology. Recurrent topics in Hiroshi Sato's work include Renal Diseases and Glomerulopathies (42 papers), Acute Myocardial Infarction Research (33 papers) and Cardiac Imaging and Diagnostics (25 papers). Hiroshi Sato is often cited by papers focused on Renal Diseases and Glomerulopathies (42 papers), Acute Myocardial Infarction Research (33 papers) and Cardiac Imaging and Diagnostics (25 papers). Hiroshi Sato collaborates with scholars based in Japan, United States and Canada. Hiroshi Sato's co-authors include Masatsugu Hori, Salim Yusuf, Chitr Sitthi‐Amorn, Karen Sliwa, Steven Hawken, Mohammad Zubaid, Stephanie Ôunpuu, Kathleen Ngu Blackett, Wael Almahmeed and Annika Rosengren and has published in prestigious journals such as Nature, Science and The Lancet.

In The Last Decade

Hiroshi Sato

306 papers receiving 10.5k citations

Hit Papers

Association of psychosoci... 2002 2026 2010 2018 2004 2002 2006 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Association of psychosocial risk factors with risk of acute myocardial infarction in 11 119 cases and 13 648 controls from 52 countries (the INTERHEART study): case-control study
    2004 1.7k citations Hiroshi Sato et al. profile →
  2. Functional SNPs in the lymphotoxin-α gene that are associated with susceptibility to myocardial infarction
    2002 696 citations Hiroshi Sato, Masatsugu Hori et al. profile →
  3. Identification of a novel non-coding RNA, MIAT, that confers risk of myocardial infarction
    2006 519 citations Hiroshi Sato, Hiroya Mizuno et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroshi Sato Japan 49 3.9k 2.6k 1.6k 931 901 319 10.9k
Erik Ingelsson Sweden 63 3.3k 0.8× 2.9k 1.1× 1.5k 1.0× 847 0.9× 718 0.8× 209 12.8k
Kenneth Caidahl Sweden 53 5.0k 1.3× 2.3k 0.9× 1.5k 0.9× 603 0.6× 434 0.5× 323 11.1k
Guðný Eiríksdóttir Iceland 58 2.8k 0.7× 1.9k 0.7× 2.4k 1.5× 921 1.0× 646 0.7× 199 13.3k
Gary H. Gibbons United States 56 3.8k 1.0× 4.4k 1.7× 2.1k 1.4× 416 0.4× 988 1.1× 153 11.4k
Harold Snieder Netherlands 65 3.2k 0.8× 2.9k 1.1× 979 0.6× 627 0.7× 422 0.5× 404 15.4k
Myron A. Waclawiw United States 56 4.1k 1.0× 3.1k 1.2× 2.0k 1.3× 639 0.7× 709 0.8× 139 14.9k
Paul Welsh United Kingdom 64 3.3k 0.8× 1.7k 0.6× 1.6k 1.0× 693 0.7× 450 0.5× 302 12.1k
Tom Wilsgaard Norway 63 3.5k 0.9× 1.1k 0.4× 2.4k 1.5× 1.2k 1.3× 495 0.5× 360 13.5k
Tanja Zeller Germany 48 4.0k 1.0× 2.7k 1.0× 1.4k 0.9× 296 0.3× 1.2k 1.4× 351 9.8k
Peter P. Liu Canada 68 9.6k 2.4× 3.5k 1.4× 2.7k 1.7× 976 1.0× 734 0.8× 197 18.6k

Countries citing papers authored by Hiroshi Sato

Since Specialization
Citations

This map shows the geographic impact of Hiroshi Sato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Sato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Sato more than expected).

Fields of papers citing papers by Hiroshi Sato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Sato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Sato. The network helps show where Hiroshi Sato may publish in the future.

Co-authorship network of co-authors of Hiroshi Sato

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Sato. A scholar is included among the top collaborators of Hiroshi Sato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Sato. Hiroshi Sato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaneko, Kaichi, Sei Muraoka, Hiroshi Sato, et al.. (2024). Comparison of Efficacy of Romosozumab With Denosumab and Risedronate in Patients Newly Initiating Glucocorticoid Therapy. The Journal of Clinical Endocrinology & Metabolism. 110(8). e2778–e2786. 2 indexed citations
2.
Sotomi, Yohei, Shungo Hikoso, Sho Komukai, et al.. (2023). Individual acute-phase bleeding and thrombotic risk balance assessment in patients undergoing percutaneous coronary intervention for acute myocardial infarction. SHILAP Revista de lepidopterología. 28. 100292–100292.
3.
Matsuoka, Yuki, Yohei Sotomi, Shungo Hikoso, et al.. (2023). The Prognostic Impact of In-Hospital Major Bleeding and Recurrence of Myocardial Infarction during Acute Phase after Percutaneous Coronary Intervention for Acute Myocardial Infarction. Journal of Atherosclerosis and Thrombosis. 31(2). 158–170. 1 indexed citations
4.
Kawaguchi, Takehiko, Toshiyuki Imasawa, Moritoshi Kadomura, et al.. (2021). Focal segmental glomerulosclerosis histologic variants and renal outcomes based on nephrotic syndrome, immunosuppression and proteinuria remission. Nephrology Dialysis Transplantation. 37(9). 1679–1690. 5 indexed citations
5.
6.
Nishio, Junko, Satoshi Mizutani, Natsuko Kusunoki, et al.. (2020). Effects of CX3CL1 inhibition on murine bleomycin-induced interstitial pneumonia. SHILAP Revista de lepidopterología. 18. 3254696822–3254696822. 2 indexed citations
7.
Sato, Hiroshi, et al.. (2020). Increasing teachers’ behavior-specific praise using self-monitoring and a peer teacher’s feedback: the effect on children’s academic engagement. Preventing School Failure Alternative Education for Children and Youth. 64(4). 271–280. 3 indexed citations
8.
Shimada, Satoshi, Takuo Hirose, Chika Takahashi, et al.. (2018). Pathophysiological and molecular mechanisms involved in renal congestion in a novel rat model. Scientific Reports. 8(1). 16808–16808. 47 indexed citations
9.
Sato, Emiko, Takefumi Mori, Michihiro Satoh, et al.. (2016). Urinary angiotensinogen excretion is associated with blood pressure in obese young adults. Clinical and Experimental Hypertension. 38(2). 203–208. 8 indexed citations
10.
Doyle, Frank, Hannah McGee, Ronán Conroy, et al.. (2015). Systematic Review and Individual Patient Data Meta-Analysis of Sex Differences in Depression and Prognosis in Persons With Myocardial Infarction. Psychosomatic Medicine. 77(4). 419–428. 88 indexed citations
11.
Edahiro, Ryuya, Yasuhiko Sakata, Yasuhiko Sakata, et al.. (2014). Association of lifestyle-related factors with circadian onset patterns of acute myocardial infarction: a prospective observational study in Japan. BMJ Open. 4(6). e005067–e005067. 8 indexed citations
12.
Loo, Hanna M. van, Edwin R. van den Heuvel, Robert A. Schoevers, et al.. (2014). Sex dependent risk factors for mortality after myocardial infarction: individual patient data meta-analysis. BMC Medicine. 12(1). 242–242. 20 indexed citations
13.
Usami, Masaya, Yasuhiko Sakata, Daisaku Nakatani, et al.. (2013). Clinical impact of acute hyperglycemia on development of diabetes mellitus in non-diabetic patients with acute myocardial infarction. Journal of Cardiology. 63(4). 274–280. 11 indexed citations
14.
Toyohara, Takafumi, Yasutoshi Akiyama, Takehiro Suzuki, et al.. (2010). Metabolomic profiling of uremic solutes in CKD patients. Hypertension Research. 33(9). 944–952. 121 indexed citations
15.
Sakata, Yasuhiko, Masahiko Shimizu, Shinichiro Suna, et al.. (2009). Biomarkers, single nucleotide polymorphisms and cardiovascular risk after acute myocardial infarction : observations from the Osaka Acute Coronary Insufficiency Study (OACIS). Circulation. 73(1). 25. 1 indexed citations
16.
Takahashi, Hiroko, Yoshihiro Maruo, Asami Mori, et al.. (2008). Effect of D256N and Y483D on Propofol Glucuronidation by Human Uridine 5′‐diphosphate Glucuronosyltransferase (UGT1A9). Basic & Clinical Pharmacology & Toxicology. 103(2). 131–136. 44 indexed citations
17.
Tang, Xian‐Liang, Gregg Rokosh, Santosh K. Sanganalmath, et al.. (2008). Abstract 358: Beneficial Effects of Cardiac Progenitor Cells on LV Function 1 Year after Treatment in Rats with Myocardial Infarction. Circulation. 118. 1 indexed citations
18.
Saito, Takao, Hiroshi Sato, Shinichi Oikawa, et al.. (1993). Lipoprotein Glomerulopathy. American Journal of Nephrology. 13(1). 64–68. 48 indexed citations
19.
Kitakaze, Masafumi, Masatsugu Hori, Hiroshi Sato, et al.. (1990). -0742-ENDOGENOUS ADENOSINE INHIBITS FORMATION OF MICROTHROMBOEMBOLISM IN ISCHEMIC MYOCARDIUM. Japanese Circulation Journal-english Edition. 54(7). 922–923. 3 indexed citations
20.
Mochizuki, Takatoshi, Hiroshi Sato, Masahiko Iizuka, et al.. (1986). ANALYSIS OF THE RELATION BETWEEN LEFT ATRIAL PRESSURE AND α-HUMAN NATRIURETIC PEPTIDE BLOOD CONCENTRATION : Atrial Natriuretic Polypeptide (I) : PROCEEDINGS OF THE 50th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY. Japanese Circulation Journal-english Edition. 50(8). 727–728. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erik Ingelsson Breakdown of academic impact, for papers by Kenneth Caidahl Breakdown of academic impact, for papers by Guðný Eiríksdóttir Breakdown of academic impact, for papers by Gary H. Gibbons Breakdown of academic impact, for papers by Harold Snieder Breakdown of academic impact, for papers by Myron A. Waclawiw Breakdown of academic impact, for papers by Paul Welsh Breakdown of academic impact, for papers by Tom Wilsgaard Breakdown of academic impact, for papers by Tanja Zeller Breakdown of academic impact, for papers by Peter P. Liu
Rankless by CCL
2026